Aviceda Therapeutics Is A Lateclinical Stagebiotechnology Company Based In Cambridgemassachusettsfounded In 2018Thecompany Focuses On Harnessing Thebody S Immunesystem To Modulateinflammationutilizing Highly Selectiveligands And Glycobiologyinitially Known As Aviceda Ophthalmicsit Has Expanded Its Mission To Develop Immuno Modulators For Chronic Inflammation And Various Diseasesincluding Ocular And Systemic Conditions Thecompany Employs Its Proprietary Halosa C Nanotechnology Platform To Createinnovativetreatmentsoneof Its Clinical Stagecandidatesavd 104Is Designed To Treat Geographic Atrophy Secondary To Agerelated Macular Degenerationamdby Modulating Inflammatory Pathwaysaviceda S Pipelinealso Includes Products Targeting Immunologyfibrosisoncologyand Neurologyadditionallyaviceda Has A Subsidiaryaviceda Glycotechltd In Belfastfocusing On Oncology And Immunologic Therapiesand Collaborates With Academic Partners In Various Regionsthecompany Has Raised $287 16 Million In Funding From Notableinvestors
No conferences found for this company.
| Company Name | Aviceda Therapeutics Inc |
| Country |
United States
|
| Address | One Broadway 14th Floor Cambridge Ma 02142 |
| Telephone | Login to View |
| Login to View |
